ML wins Federal Circuit victory for client Merck

November 2019

In a victory for our client Merck, the Federal Circuit vacated the PTAB’s judgment that a key claim of a competitor’s patent relating to stabilization of vaccines was non-obvious.  Read our client’s opening brief, reply brief, and the opinion.

Jump to Page

By using this site, you agree to our updated Privacy Policy and our Terms of Use.